JP2004531224A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004531224A5 JP2004531224A5 JP2002559452A JP2002559452A JP2004531224A5 JP 2004531224 A5 JP2004531224 A5 JP 2004531224A5 JP 2002559452 A JP2002559452 A JP 2002559452A JP 2002559452 A JP2002559452 A JP 2002559452A JP 2004531224 A5 JP2004531224 A5 JP 2004531224A5
- Authority
- JP
- Japan
- Prior art keywords
- adp
- fusion protein
- membrane
- aggregation
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0100119.7A GB0100119D0 (en) | 2001-01-03 | 2001-01-03 | Materials and methods relating to protein aggregation in neurodegenerative disease |
| PCT/GB2002/000005 WO2002059150A2 (en) | 2001-01-03 | 2002-01-02 | Materials and methods relating to protein aggregation in neurodegenerative disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004531224A JP2004531224A (ja) | 2004-10-14 |
| JP2004531224A5 true JP2004531224A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4580618B2 JP4580618B2 (ja) | 2010-11-17 |
Family
ID=9906201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002559452A Expired - Lifetime JP4580618B2 (ja) | 2001-01-03 | 2002-01-02 | 神経変性疾患におけるタンパク質凝集に関する材料および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7834237B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1348029B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4580618B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE548453T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002217310B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2433535C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1348029T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2382457T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0100119D0 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1348029E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002059150A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0104685D0 (en) * | 2001-02-26 | 2001-04-11 | Leuven K U Res & Dev | Tau-opathy model |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| GB0117326D0 (en) | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
| WO2004007722A2 (en) * | 2002-07-12 | 2004-01-22 | Axon Neuroscience Forschungs- Und Entwicklungs Gmbh | Transgenic animal expressing alzheimer’s tau protein |
| EP1516930A1 (en) * | 2003-09-16 | 2005-03-23 | Georg-August Universität Göttingen | Cellular model of tauopathies for lead identification and drug discovery |
| DE602005016537D1 (de) * | 2004-03-31 | 2009-10-22 | Anges Mg Inc | Testverfahren zur identifizierung eines kandidatenarzneistoffs |
| ES2770067T3 (es) | 2004-05-11 | 2020-06-30 | Ncardia Ag | Descubrimiento de fármacos basado en células diferenciadas in vitro |
| JP5186212B2 (ja) | 2004-09-23 | 2013-04-17 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム塩化物(mtc)などのジアミノフェノチアジニウム化合物を化学合成および精製する方法 |
| WO2007066809A1 (ja) * | 2005-12-06 | 2007-06-14 | Tokyo Metropolitan Organization For Medical Research | タンパク質重合体の重合核となりうるタンパク質又はその重合体が導入された細胞及びその製造法 |
| DK2004155T3 (en) | 2006-03-29 | 2018-04-30 | Wista Lab Ltd | PROTEIN AGGREGATION INHIBITORS |
| CN104119294B (zh) | 2006-03-29 | 2018-10-30 | 维斯塔实验室有限公司 | 3,7-二氨基-10h-吩噻嗪化合物的制备方法 |
| PT2954932T (pt) | 2007-10-03 | 2018-12-12 | Wista Lab Ltd | Utilização terapêutica de diaminofenotiazinas |
| WO2012106363A2 (en) | 2011-01-31 | 2012-08-09 | Intellect Neurosciences Inc. | Treatment of tauopathies |
| KR101888713B1 (ko) | 2011-02-11 | 2018-08-14 | 위스타 레보레이토리스 리미티드 | 페노티아진 디아미늄 염 및 이의 용도 |
| WO2012162179A1 (en) | 2011-05-20 | 2012-11-29 | Oligomerix, Inc. | Tau protease compositions and methods of use |
| PL3487505T3 (pl) | 2016-07-25 | 2023-10-09 | Wista Laboratories Ltd. | Podawanie i dawkowanie diaminofenotiazyn |
| CN111094327A (zh) * | 2017-08-16 | 2020-05-01 | Lgv1有限公司 | Bpifb4蛋白的用于神经元疾病和损伤的vtft同种型 |
| CN113874078B (zh) | 2019-04-05 | 2025-05-06 | Tauc3生物制品有限公司 | 抗tauc3抗体及其应用 |
| GB201909454D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Enhancers |
| GB201909493D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
| GB201909506D0 (en) | 2019-07-02 | 2019-08-14 | Wista Lab Ltd | Synaptopathies |
| CN113943766B (zh) * | 2021-11-26 | 2024-01-26 | 守正创新生物科技(天津)有限公司 | 一种抗糖化寡肽-5(AdP)的制备及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE569430A (cg-RX-API-DMAC7.html) | 1957-07-17 | |||
| GB8724412D0 (en) | 1987-10-19 | 1987-11-25 | Medical Res Council | Protein |
| US5571666A (en) | 1988-10-28 | 1996-11-05 | Oklahoma Medical Research Foundation | Thiazine dyes used to inactivate HIV in biological fluids |
| JPH0725786A (ja) | 1990-05-16 | 1995-01-27 | Univ Rockefeller | アルツハイマー病を伴うアミロイドーシスの治療 |
| US5912410A (en) | 1990-06-15 | 1999-06-15 | Scios Inc. | Transgenic non-human mice displaying the amyloid-forming pathology of alzheimer's disease |
| CA2110488A1 (en) | 1991-07-10 | 1993-01-21 | Franceska Fieuws | Fluorochemical water- and oil-repellent treating compositions |
| WO1993003369A1 (en) | 1991-08-01 | 1993-02-18 | Voorheis Paul H | Diagnostic method for alzheimer's disease |
| WO1993011231A1 (en) | 1991-12-06 | 1993-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Tools for the diagnosis and treatment of alzheimer's disease |
| GB9316727D0 (en) | 1993-08-12 | 1993-09-29 | Inst Of Psychiatry | Models of alzheimers's disease |
| GB9317193D0 (en) | 1993-08-18 | 1993-10-06 | Zeneca Ltd | Method |
| FR2722695B1 (fr) | 1994-07-22 | 1997-04-25 | Demic Lab Sa | Ustensile de badigeonnage cutane par frottement a usage medical |
| WO1996004915A1 (en) | 1994-08-08 | 1996-02-22 | Albert Einstein College Of Medicine Of Yeshiva University | Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes |
| DE4430091A1 (de) | 1994-08-25 | 1996-02-29 | Bayer Ag | Verwendung von N-substituierten Phenothiazinen |
| GB9506197D0 (en) * | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| US5804601A (en) | 1995-04-10 | 1998-09-08 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamic acid compounds, their production and use |
| US5898094A (en) | 1996-10-21 | 1999-04-27 | University Of South Florida | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes |
| WO1999062548A1 (en) | 1998-06-01 | 1999-12-09 | Advanced Research And Technology Institute | Methods and compositions for diagnosing tauopathies |
| DE19920514A1 (de) * | 1999-05-05 | 2000-11-16 | Boehringer Ingelheim Pharma | Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten |
| WO2001053340A2 (en) | 2000-01-21 | 2001-07-26 | Pharmacia & Upjohn Company | Transgenic mouse model of human neurodegenerative disease |
| JP2001352860A (ja) * | 2000-06-15 | 2001-12-25 | Inst Of Physical & Chemical Res | 老年期痴呆症で生じる神経原線維変化を示すマウス |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| GB0117326D0 (en) | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
| US20030217370A1 (en) | 2002-05-16 | 2003-11-20 | Giasson Benoit I. | Transgenic animal expressing alpha-synuclein and uses thereof |
| US6953974B2 (en) * | 2003-08-26 | 2005-10-11 | Texas Instruments Incorporated | EEPROM device and method for providing lower programming voltage |
| GB0322756D0 (en) | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
| WO2006032879A2 (en) | 2004-09-23 | 2006-03-30 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
-
2001
- 2001-01-03 GB GBGB0100119.7A patent/GB0100119D0/en not_active Ceased
-
2002
- 2002-01-02 EP EP02734847A patent/EP1348029B1/en not_active Expired - Lifetime
- 2002-01-02 WO PCT/GB2002/000005 patent/WO2002059150A2/en not_active Ceased
- 2002-01-02 PT PT02734847T patent/PT1348029E/pt unknown
- 2002-01-02 US US10/451,367 patent/US7834237B2/en not_active Expired - Lifetime
- 2002-01-02 DK DK02734847.3T patent/DK1348029T3/da active
- 2002-01-02 ES ES02734847T patent/ES2382457T3/es not_active Expired - Lifetime
- 2002-01-02 CA CA2433535A patent/CA2433535C/en not_active Expired - Lifetime
- 2002-01-02 JP JP2002559452A patent/JP4580618B2/ja not_active Expired - Lifetime
- 2002-01-02 AT AT02734847T patent/ATE548453T1/de active
- 2002-01-02 AU AU2002217310A patent/AU2002217310B2/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bates et al. | Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests | |
| Lehnert et al. | Mechanoreceptor synapses in the brainstem shape the central representation of touch | |
| ES2230551T3 (es) | Procedimientos para ayudar al diagnostico de la enfermedad de alzheimer mediante la medicion del peptido (x- 41)amiloide beta y de la proteina tau. | |
| Corsetti et al. | Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models | |
| Harris et al. | Alzheimer’s disease patient-derived high-molecular-weight tau impairs bursting in hippocampal neurons | |
| CN1225723A (zh) | 检测针对组织转谷氨酰胺酶(tTG)的抗体的免疫方法,tTG在诊断和治疗控制中的用途,和含tTG的口服药剂 | |
| Dhillon et al. | Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils | |
| Toma et al. | Perivascular neurons instruct 3D vascular lattice formation via neurovascular contact | |
| PT1633189T (pt) | Fragmentos truncados de alfa-sinucleína em doença com corpos de lewy | |
| Shen et al. | FPS-ZM1 alleviates neuroinflammation in focal cerebral ischemia rats via blocking ligand/RAGE/DIAPH1 pathway | |
| JP2009544284A5 (cg-RX-API-DMAC7.html) | ||
| EA013752B1 (ru) | Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний | |
| Faustini et al. | Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate | |
| CA2433535A1 (en) | Materials and methods relating to protein aggregation in neurodegenerative disease | |
| Wintgens et al. | Plasma myostatin measured by a competitive ELISA using a highly specific antiserum | |
| Stoyka et al. | Templated α-synuclein inclusion formation is independent of endogenous tau | |
| CA3138808A1 (en) | Detection of biomarkers associated with brugada syndrome | |
| TW562926B (en) | Method for testing renal diseases | |
| Xie et al. | Raptin, a sleep-induced hypothalamic hormone, suppresses appetite and obesity | |
| Hawkes et al. | Immunotherapy as treatment for Alzheimer’s disease | |
| CN120721981B (zh) | scEMC10在治疗和诊断脑血管内皮细胞衰老中的应用 | |
| WO2017062270A1 (en) | Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies | |
| KR19990007893A (ko) | 중추신경계(cns) 축삭 성장 모듈레이터, 이를 구현 및 사용하는 조성물, 세포 및 방법 | |
| Brendza et al. | Amyloid-β immunotherapies in mice and men | |
| JP2007530069A6 (ja) | イオンチャネル |